CLOSE

Benchmark Investments

PGIM India Healthcare Fund-Reg(G)

very highequitypharma & health care
12.14 -0.03(-0.25%) NAV as on 20 Aug 2026
3.58 % 1 M
21.52 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

2.58

As on 31 Jul, 2026
Age :

1 yrs 8 m

Since 06 12 ,2024
Exit Load :

0.5%

AUM :

111.64 Crs

Portfolio Price To Book Value :

10.63

Investing Style :

Large Growth

Min. Investment :

SIP 1000 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Anandha Padmanabhan Anjeneyan,Utsav Mehta,Sharma Vivek

Launch Date :

06-Dec-24

Scheme Benchmark :

NA

FUND OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jul 31 ,2026
Others 4.53 %
Equity 95.47 %

TOP HOLDINGS

Sun Pharmaceutical Industries...10.86 %
Divi's Laboratories Ltd.10.35 %
Torrent Pharmaceuticals Ltd.9.38 %
Aster DM Quality Care Ltd.6.21 %
Max Healthcare Institute Ltd.5.86 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs59.38
Hospital & Healthcare Services27.54
Miscellaneous3.68
Chemicals2.81
Insurance0.89
See All Sectors

5-YEARS HISTORY

Financial Year2024-20252025-2026
NAV in Rs (as on 31-Mar-2026)9.379.58
Net Assets(Rs Crores) (as on 31-Mar-2026) 104.18 85.19
Scheme Returns(%)(Absolute)-6.303.79
B'mark Returns(%)(Absolute)NANA
Category Rank91/10222/120

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2026-202718.06NANANA
2025-20265.55-3.443.04-2.64
2024-2025NANANA-7.32

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

PGIM India Healthcare Fund-Reg(G)Very HighEquity12.14-0.03(-0.25%)NAV As on 20 Aug, 202606-Dec-2024Inception Date111.64AUM In Cr.21.52%1YNA%3YNA%5Y12.05%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity517.81-1.09(-0.21%)NAV As on 20 Aug, 202614-Jul-1999Inception Date5,399.88AUM In Cr.18.89%1Y23.21%3Y18.09%5Y16.37%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity43.370.17(0.39%)NAV As on 20 Aug, 202613-Jul-2018Inception Date6,802.61AUM In Cr.8.13%1Y22.13%3Y15.91%5Y19.83%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity45.370.10(0.21%)NAV As on 20 Aug, 202602-Jul-2018Inception Date3,442.28AUM In Cr.17.37%1Y21.07%3Y14.51%5Y20.42%Since Inception
LIC MF Healthcare Fund-Reg(G)Very HighEquity33.72-0.12(-0.36%)NAV As on 20 Aug, 202628-Feb-2019Inception Date97.66AUM In Cr.13.71%1Y20.85%3Y11.47%5Y17.66%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd